Core Laboratories N.V. (CLB)
NYSE: CLB · IEX Real-Time Price · USD
18.09
+0.05 (0.28%)
May 20, 2024, 10:31 AM EDT - Market open

Core Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 1994
Revenue
509.79489.74470.25487.27668.21
Upgrade
Revenue Growth (YoY)
4.10%4.14%-3.49%-27.08%-4.66%
Upgrade
Cost of Revenue
399.96393.66367.9374.77495.58
Upgrade
Gross Profit
109.8396.08102.36112.5172.63
Upgrade
Selling, General & Admin
40.2638.1244.1734.0348.02
Upgrade
Other Operating Expenses
14.9316.4412.92155.2727.92
Upgrade
Operating Expenses
55.1954.5657.09189.3175.95
Upgrade
Operating Income
54.6441.5245.26-76.8196.68
Upgrade
Interest Expense / Income
13.4311.579.1514.3714.69
Upgrade
Other Expense / Income
0.350.210.490.56-7.7
Upgrade
Pretax Income
40.8629.7535.62-91.7489.69
Upgrade
Income Tax
4.1910.315.895.9-12.29
Upgrade
Net Income
36.6819.4519.73-97.64101.98
Upgrade
Net Income Growth
88.53%-1.39%--28.24%
Upgrade
Shares Outstanding (Basic)
4746464444
Upgrade
Shares Outstanding (Diluted)
4847474445
Upgrade
Shares Change
1.52%0.26%4.98%-0.38%0.39%
Upgrade
EPS (Basic)
0.790.420.44-2.202.30
Upgrade
EPS (Diluted)
0.780.420.43-2.202.28
Upgrade
EPS Growth
85.71%-2.33%--27.37%
Upgrade
Free Cash Flow
14.7616.623.447.2267.97
Upgrade
Free Cash Flow Per Share
0.320.360.511.061.53
Upgrade
Dividend Per Share
0.0400.0400.0400.2802.200
Upgrade
Dividend Growth
0%0%-85.71%-87.27%0%
Upgrade
Gross Margin
21.54%19.62%21.77%23.09%25.83%
Upgrade
Operating Margin
10.72%8.48%9.63%-15.76%14.47%
Upgrade
Profit Margin
7.19%3.97%4.19%-20.04%15.26%
Upgrade
Free Cash Flow Margin
2.90%3.39%4.98%9.69%10.17%
Upgrade
Effective Tax Rate
10.24%34.61%44.62%--13.70%
Upgrade
EBITDA
70.0758.4863.29-56.5126.99
Upgrade
EBITDA Margin
13.75%11.94%13.46%-11.60%19.00%
Upgrade
Depreciation & Amortization
15.7817.1618.5220.8722.61
Upgrade
EBIT
54.2941.3244.77-77.37104.38
Upgrade
EBIT Margin
10.65%8.44%9.52%-15.88%15.62%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).